JeremyDavidKeenanMD

Cornea & External Disease, Uveitis

Assistant Professor of Ophthalmology Francis I. Proctor Foundation

Dr. Keenan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
95 Kirkham St
San Francisco, CA 94122
Phone+1 415-476-1442

Fax+1 415-502-2521

University of Illinois College of Medicine at ChicagoResidency, Ophthalmology, 2004 - 2007
New York Medical College at St Vincent's Hospital and Medical Center of New YorkInternship, Transitional Year, 2003 - 2004
Columbia University Vagelos College of Physicians and SurgeonsClass of 2003

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Antioxidants for Prevention of Cataracts Follow-up Study Start of enrollment: 2012 Aug 01
Completed
Not Applicable
Mitomycin C Trabeculectomy Trial for Glaucoma in Ethiopia Start of enrollment: 2015 Mar 01
Withdrawn
Not Applicable
Intestinal Microbiome Post-Azythromycin/Albendazole Treatment Start of enrollment: 2017 Jan 01
Withdrawn
Phase 4
Village-Integrated Eye Worker Trial II - Pilot Start of enrollment: 2018 May 31
Completed
Not Applicable
Parasitic Ulcer Treatment Trial Pilot Start of enrollment: 2018 Jan 01
Active, not recruiting
Phase 2
Village-Integrated Eye Worker Trial II Start of enrollment: 2019 Apr 21
Recruiting
Not Applicable
Sanitation, Water, and Instruction in Face-washing for Trachoma I/II Start of enrollment: 2015 Dec 05
Recruiting
Phase 3
Roles: Contact, Principal Investigator
Micro vs. Standard Trabeculectomy Study Start of enrollment: 2016 Mar 01
Unknown status
Not Applicable
Roles: Principal Investigator, Contact
Parasitic Ulcer Treatment Trial Start of enrollment: 2024 Apr 01
Not yet recruiting
Phase 3
Roles: Principal Investigator, Sponsor-Investigator, Contact
Join now to see all

PubMed

Evaluation of a Novel Virtual Reality Simulated Alternate Cover Test to Assess Strabismus: A Prospective, Masked Study.
Diego Martinez Mori, Ashika Kuchhangi, Jessica Tame, Karen Cooper, Leila Hajkazemshirazi
American Journal of Ophthalmology. 2025-01-01
Correlation of Clinical Severity of Trachomatous Inflammation and Chlamydia trachomatis Bacterial Load.
Louisa Lu, Ali Fauci, Quintin R Richardson, Hamidah Mahmud, John M Nesemann
The American Journal of Tropical Medicine and Hygiene. 2024-12-04
Assessment of Spillover of Antimicrobial Resistance to Untreated Children 7-12 Years Old After Mass Drug Administration of Azithromycin for Child Survival in Niger: A ...
Brittany Peterson, Ahmed M Arzika, Abdou Amza, Ramatou Maliki, Alio Mankara Karamba
Clinical Infectious Diseases. 2024-11-22

Journal Articles

Accuracy of Pinhole Visual Acuity at an Urban Indian Hospital
Jeremy Keenan, MD, Nature
Mass Azithromycin Distribution for Hyperendemic Trachoma Following a Cluster-Randomized Trial: A Continuation Study of Randomly Reassigned Subclusters (TANA II)
Jeremy D Keenan, Thomas M Lietman, PLoS One
F Effect of Antibiotics on Short-Term Growth Among Children in Burkina Faso: A Randomized Trial
Thomas M Lietman, Jeremy D Keenan, The American Journal of Tropical Medicine and Hygiene
School-Based Versus Community-Based Sampling for Trachoma Surveillance
Thomas M Lietman, Jeremy D Keenan, The American Journal of Tropical Medicine and Hygiene
The Effect of Antibiotic Selection Pressure on the Nasopharyngeal Macrolide Resistome: A Cluster-Randomized Trial
Jeremy D Keenan, Thomas M Lietman, Clinical Infectious Diseases
Join now to see all

Giving an Antibiotic to All Children Under 5 in Africa Saves LivesAugust 21st, 2024
Follow-up Study: Mass Azithromycin Still Tied to Fewer Child DeathsJune 6th, 2019
Macrolide Resistance in MORDOR I — A Cluster-Randomized Trial in NigerJune 5th, 2019
Join now to see all

Planning Grant For Parasitic Ulcer Treatment TrialNational Eye Institute2012
Optimal Trachoma Control After Mass Antibiotic DistributionsNational Eye Institute2008–2011